Advertisement
Screener

Definium Therapeutics, Inc. (DFTX) Foreign Currency Transaction Gain (Loss), before Tax

2.8 / 5 stars · 68/120 Roast Me

Definium Therapeutics, Inc. Foreign Currency Transaction Gain (Loss), before Tax

Definium Therapeutics, Inc. (DFTX) reported Foreign Currency Transaction Gain (Loss), before Tax of -$32.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Other Income

us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-06

  • Definium Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was -$32.00K.
  • Definium Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was -$44.00K.
  • Definium Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was -$24.00K.
  • Definium Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was -$39.00K.
  • Definium Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2025 was -$131.00K.
  • Definium Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$638.00K, a 506.37% decline from fiscal 2023.
  • Definium Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2023 was $157.00K, a 19.49% decline from fiscal 2022.
  • Definium Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2022 was $195.00K.
Period endForeign Currency Transaction Gain (Loss), before Tax 3 monthForeign Currency Transaction Gain (Loss), before Tax 6 monthForeign Currency Transaction Gain (Loss), before Tax 7 monthForeign Currency Transaction Gain (Loss), before Tax 9 monthForeign Currency Transaction Gain (Loss), before Tax 12 month
2026-06-30-$32.00K
10-Q · filed 2026-08-06
-$76.00K
10-Q · filed 2026-08-06
-$100.00K
derived: sum of 3 quarters · filed 2026-08-06
-$139.00K
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$44.00K
10-Q · filed 2026-05-07
-$68.00K
derived: sum of 2 quarters · filed 2026-05-07
-$107.00K
derived: sum of 3 quarters · filed 2026-05-07
-$156.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$24.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$63.00K
derived: sum of 2 quarters · filed 2026-02-26
-$112.00K
derived: sum of 3 quarters · filed 2026-08-06
-$131.00K
10-K · filed 2026-02-26
2025-09-30-$39.00K
10-Q · filed 2025-11-06
-$88.00K
derived: sum of 2 quarters · filed 2026-08-06
-$107.00K
10-Q · filed 2025-11-06
-$156.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$49.00K
10-Q · filed 2026-08-06
-$68.00K
10-Q · filed 2026-08-06
-$117.00K
derived: sum of 3 quarters · filed 2026-08-06
-$149.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$19.00K
10-Q · filed 2026-05-07
-$68.00K
derived: sum of 2 quarters · filed 2026-05-07
-$100.00K
derived: sum of 3 quarters · filed 2026-05-07
-$132.00K
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31-$49.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$81.00K
derived: sum of 2 quarters · filed 2026-02-26
-$113.00K
derived: sum of 3 quarters · filed 2026-02-26
-$638.00K
10-K · filed 2026-02-26
2024-09-30-$32.00K
10-Q · filed 2025-11-06
-$64.00K
derived: sum of 2 quarters · filed 2025-11-06
-$589.00K
10-Q · filed 2025-11-06
-$188.00K
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30-$32.00K
10-Q · filed 2025-07-31
-$557.00K
10-Q · filed 2025-07-31
-$156.00K
derived: sum of 3 quarters · filed 2025-07-31
-$595.00K
derived: sum of 4 quarters · filed 2025-07-31
2024-03-31-$525.00K
10-Q · filed 2025-05-08
-$124.00K
derived: sum of 2 quarters · filed 2025-05-08
-$563.00K
derived: sum of 3 quarters · filed 2025-05-08
-$316.00K
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$401.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06
-$38.00K
derived: sum of 2 quarters · filed 2025-03-06
$209.00K
derived: sum of 3 quarters · filed 2025-03-06
$157.00K
10-K · filed 2025-03-06
2023-09-30-$439.00K
10-Q · filed 2024-11-07
-$192.00K
derived: sum of 2 quarters · filed 2024-11-07
-$244.00K
10-Q · filed 2024-11-07
-$143.00K
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$247.00K
10-Q · filed 2024-08-13
$195.00K
10-Q · filed 2024-08-13
$296.00K
derived: sum of 3 quarters · filed 2024-08-13
$434.00K
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31-$52.00K
10-Q · filed 2024-05-08
$49.00K
derived: sum of 2 quarters · filed 2024-05-08
$187.00K
derived: sum of 3 quarters · filed 2024-05-08
$98.00K
derived: sum of 4 quarters · filed 2024-05-08
2022-12-31$101.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$239.00K
derived: sum of 2 quarters · filed 2024-02-28
$150.00K
derived: sum of 3 quarters · filed 2024-02-28
$195.00K
10-K · filed 2024-02-28
2022-09-30$138.00K
10-Q · filed 2023-11-02
$49.00K
derived: sum of 2 quarters · filed 2023-11-02
$94.00K
10-Q · filed 2023-11-02
-$86.00K
derived: sum of 4 quarters · filed 2023-11-02
2022-06-30-$89.00K
10-Q · filed 2023-08-03
-$44.00K
10-Q · filed 2023-08-03
-$224.00K
derived: sum of 3 quarters · filed 2023-08-03
-$264.00K
derived: sum of 4 quarters · filed 2023-08-03
2022-03-31$45.00K
10-Q · filed 2023-05-04
-$135.00K
derived: sum of 2 quarters · filed 2023-05-04
-$175.00K
derived: sum of 3 quarters · filed 2023-05-04
-$210.00K
derived: sum of 4 quarters · filed 2023-05-04
2021-12-31-$180.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09
-$220.00K
derived: sum of 2 quarters · filed 2023-03-09
-$255.00K
derived: sum of 3 quarters · filed 2023-03-09
-$86.00K
10-K · filed 2023-03-09
2021-09-30-$40.00K
10-Q · filed 2022-11-10
-$75.00K
derived: sum of 2 quarters · filed 2022-11-10
$94.00K
10-Q · filed 2022-11-10
2021-06-30-$35.00K
10-Q · filed 2022-08-11
$134.00K
10-Q · filed 2022-08-11
2021-03-31$8.00K
10-Q · filed 2022-05-16
2020-12-31$130.00K
10-K · filed 2022-03-28
2019-12-31$18.00K
10-K · filed 2022-03-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cronos Group Inc. (CRON)$1.223B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B